|
已读[62]
发布： 2013/10/04 16:29:46
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ...
|
|
|
|
|
已读[61]
发布： 2013/10/04 16:29:32
Family Practice News Digital Network BARCELONA – It's taken 15 years, but newly released data are finally clearing the last shadow of doubt over metformin's safety in type 2 diabetes. Patients in the groundbreaking U.K. Prospective Diabetes Study (UKPDS) who took the drug along with a ...
|
|
|
|
|
已读[58]
发布： 2013/10/03 16:30:48
Medscape Immediately after the procedure, patients had their insulin and sulfonylurea doses reduced by 50% and ate a liquid diet for the following 2 to 3 weeks. After 1 year, the device was removed. As noted, HbA1c levels were significantly reduced at 12 months.
|
|
|
|
|
已读[60]
发布： 2013/10/03 16:30:37
PR Newswire (press release) BURLINGTON, Mass., Oct. 2, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through analysis of U.S. longitudinal patient-level claims data, dipeptidyl ...
|
|
|
|
|
已读[68]
发布： 2013/10/03 16:30:27
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ...
|
|
|
|
|
已读[58]
发布： 2013/10/03 16:30:11
Family Practice News Digital Network BARCELONA – It's taken 15 years, but newly released data are finally clearing the last shadow of doubt over metformin's safety in type 2 diabetes. Patients in the groundbreaking U.K. Prospective Diabetes Study (UKPDS) who took the drug along with a ...
|
|
|
|
|
已读[60]
发布： 2013/10/02 16:36:26
The Providence Journal BURLINGTON, Mass., Oct. 2, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through analysis of U.S. longitudinal patient-level claims data, dipeptidyl ... and more »
|
|
|
|
|
已读[55]
发布： 2013/10/02 16:36:20
Healio According to Rury R. Holman, FRCP, director of the University of Oxford Diabetes Trials Unit and honorary consultant physician to the Oxford Radcliffe Hospitals NHS Trust, the effect of the early addition of metformin to sulfonylurea does not appear to ...
|
|
|
|
|
已读[58]
发布： 2013/10/02 16:35:59
Family Practice News Digital Network BARCELONA – It's taken 15 years, but newly released data are finally clearing the last shadow of doubt over metformin's safety in type 2 diabetes. Patients in the groundbreaking U.K. Prospective Diabetes Study (UKPDS) who took the drug along with a ...
|
|
|
|
|
已读[56]
发布： 2013/10/01 16:37:01
Medscape Immediately after the procedure, patients had their insulin and sulfonylurea doses reduced by 50% and ate a liquid diet for the following 2 to 3 weeks. After 1 year, the device was removed. As noted, HbA1c levels were significantly reduced at 12 months. and more »
|
|
|
« 上一页 |
查看结果411-420共686
|
下一页 »
|
|
